Why More Startups And VCs Are Finally Pursuing the Menopause Market: ‘$600B Is Not ‘Niche’’
Gennev is proud to be highlighted in this article in Crunchbase News with a quote from our fearless leader, Jill Angelo. The changing landscape of innovation funding in women's healthcare is a win for us all.
“'We see menopause as the kick-off to the second half of life,' Angelo said in an interview. 'How we manage menopause in our 40s and 50s will determine our long-term health: Alzheimer’s, bone health and osteoporosis. More women are getting educated and making necessary lifestyle changes so their second half is as healthy as it can possibly be.'”
Learn more about what is happening for women, here.